Skip to main content
. 2020 Dec 11;2020:2872479. doi: 10.1155/2020/2872479

Figure 6.

Figure 6

Kaplan–Meier survival analysis: total and progression-free survival in patients undergoing postoperative chemotherapy. (a) The OS of patients with FGF2 overexpression was shorter in ESCC (p = 0.025); (b) the high expression of FGFR3 had a poor OS in ESCC (p = 0.05); (c) the high expression of FGFBP1 had a poor OS in ESCC (p = 0.005); (c) the PFS of patients with FGF2 overexpression was shorter in ESCC (p < 0.001); (e) the high expression of FGFR3 had a poor PFS in ESCC (p < 0.001); (f) the high expression of FGFBP1 had a poor PFS in ESCC (p < 0.001).